A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in older patients who were ...

Neuropathic pain refers to pain caused by damage or disease to the nervous system.Neuropathic pain differs in pattern from ...

Researchers have found pregabalin highly effective in reducing neuropathic pain and itch in recessive dystrophic epidermolysis bullosa (RDEB), the most prevalent and debilitating form ...

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

The resulting paper, “ Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain ...

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

The study, published today in JAMA Network Open, tracked patients hospitalized for hip fractures in Victoria, Australia from ...

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...